REDHILL BIOPHARMA LTD's ticker is RDHL and the CUSIP is 757468103. A total of 39 filers reported holding REDHILL BIOPHARMA LTD in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3,940 | -84.2% | 28,084 | -42.7% | 0.00% | – |
| Q3 2022 | $25,000 | -41.9% | 48,984 | +0.2% | 0.00% | – |
| Q2 2022 | $43,000 | 0.0% | 48,895 | +187.5% | 0.00% | – |
| Q1 2022 | $43,000 | -42.7% | 17,007 | -41.3% | 0.00% | – |
| Q4 2021 | $75,000 | -75.7% | 28,995 | -57.1% | 0.00% | – |
| Q3 2021 | $309,000 | +68.9% | 67,532 | +276.9% | 0.00% | -100.0% |
| Q3 2020 | $183,000 | -54.6% | 17,919 | -70.2% | 0.00% | -50.0% |
| Q2 2020 | $403,000 | +227.6% | 60,194 | +122.3% | 0.00% | +100.0% |
| Q1 2020 | $123,000 | -25.5% | 27,082 | -0.4% | 0.00% | 0.0% |
| Q4 2019 | $165,000 | +1962.5% | 27,182 | +2371.1% | 0.00% | – |
| Q3 2019 | $8,000 | +166.7% | 1,100 | +188.7% | 0.00% | – |
| Q1 2019 | $3,000 | -57.1% | 381 | -70.3% | 0.00% | – |
| Q4 2018 | $7,000 | -46.2% | 1,281 | -10.8% | 0.00% | – |
| Q3 2018 | $13,000 | – | 1,436 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 717,203 | $9,962,000 | 0.89% |
| BANK HAPOALIM BM | 147,504 | $2,049,000 | 0.48% |
| MENORA MIVTACHIM HOLDINGS LTD. | 246,000 | $3,417,000 | 0.19% |
| Family Management Corp | 16,500 | $229,000 | 0.13% |
| Orbimed Advisors | 564,900 | $7,846,000 | 0.09% |
| SABBY MANAGEMENT, LLC | 63,800 | $888,000 | 0.03% |
| INGALLS & SNYDER LLC | 41,550 | $577,000 | 0.03% |
| Candriam S.C.A. | 71,267 | $992,000 | 0.02% |
| MONETARY MANAGEMENT GROUP INC | 3,000 | $42,000 | 0.02% |
| D.A. DAVIDSON & CO. | 26,500 | $368,000 | 0.01% |